$999 – $1,099

29th International Congress on Prevention of Diabetes and Complications (CS...

Event Information

Share this event

Date and Time

Location

Location

Berlin

Berlin

Germany

View Map

Refund Policy

Refund Policy

No Refunds

Event description

Description

29th International Congress on Prevention of Diabetes and Complications



About Conference

Welcome to the Diabetes Meeting 2018!

With the amalgamation of peerless speakers of Diabetes 2017 Conference Series is privileged to announce its “29th Diabetes Conference which will be held during September 27-28, 2018 Berlin, Germany. We cordially welcome all the eminent researchers, students and delegates to take part in this upcoming Diabetes conference to witness invaluable scientific discussions and contribute to the future innovations in the field of Diabetes.

According to WHO, about 60 million people with diabetes in the European Region. About 10.3% of men and 9.6% of women aged 25 years and over. Worldwide, high blood glucose kills about 3.4 million people annually amongst 80% of these deaths occur in low- and middle-income countries, and almost half are people aged under 70 years. WHO projects diabetes deaths will double between 2005 and 2030. The overall risk of dying among people with diabetes is at least double the risk of their peers without diabetes. Reflecting this imperative, Conference Series is all set to host Diabetes conference in Berlin, Germany this year which will provide the future leadership in this key area for global health.

Diabetes Meeting 2018 will focus on the latest and exciting innovations in all areas of Diabetes research which offers a unique opportunity for investigators across the globe to meet, network, and perceive new scientific innovations. This year’s annual congress highlights the theme,Diabetes from Monitoring to Management which reflects the innovative progress in Diabetes research. The two days conference includes workshops, symposiums, special keynote sessions conducted by eminent and renowned speakers who excel in the field of Diabetes which include: Diabetes types and symptoms, Diabetes Complications, Diabetes and the Elderly, Clinical Diabetes and Diagnostic Approaches, Endocrinology, Metabolic Syndrome, Diabetes Associated Disorders, Diabetes Medications, Management of Diabetes, Gestational Diabetes, Alternative Medical Therapies for Diabetes, Diabetes market and Business analysis.

Berlin is the capital of Germany as well as European Union's second largest city. It is renowned for its exceptional variety of attractions, its flourishing cultural scene and a way of life that's both fast-paced and relaxed. It is a city of art, artists and museums. The sights of Berlin – from the Brandenburg Gate to the Federal Chancellery – tell the story of an entire nation. The memorial is made up of a visitor center, documentation center, open-air exhibition and the ghost stations exhibition, providing plenty of information on the Berlin Wall and its fall. A feature of Berlin, aside from its exuberance, is the way it continuously reinvents itself. It's worth checking out the Berlin Marathon which will held on the last Sunday of September, and is one of the world's largest marathons, with over 60,000 runners, in-line skaters and wheel chair athletes participating. Berlin is home to world orchestras, museums, renowned universities, entertainment venues and is host to many sporting events.

We look forward to meet you at Berlin, Germany


Sessions & Tracks



Diabetes Types and Symptoms

The incidence of type 2 diabetes mellitus has increased in children and adolescents and is linked to the rise in childhood obesity. It has been estimated that almost 40% of people with type 1 diabetes develop the condition after 30 years of age. T2DM and its comorbidities are risk factors for vascular disease later in life. Type 2 diabetes is expected to become the 7th cause of death globally by 2030. Type 2 diabetes is strongly associated with obesity, and as such the major burden is now in the middle-income and developing countries where urbanisation and recent affluence have rapidly changed lifestyles. The latest estimates show that global prevalence of 382 million people with diabetes in 2013, expected to rise to 592 million by 2035. As a result, it is imperative for health care providers to identify and treat children and adolescents with this disorder.

Diabetes Complications:

It is common for most people with diabetes to begin to develop complications after having diabetes for a number of years. Large scale research studies have shown that the chances of developing the most common complications rises significantly in proportion to each 1% increase in HbA1c levels. Uncontrolled diabetes can lead to a number of short and long-term health complications, including hypoglycemia, heart disease, nerve damage and amputation, and vision problems. There is evidence from large randomized-controlled trials that good metabolic control in both type 1 and 2 diabetes can delay the onset and progression of these complications. However, scientists are still working on developing complications

Diabetes and the Elderly:

Amongst the elderly population, type 2 diabetes is a growing problem, and a larger proportion of newly diagnosed diabetics are older. Treating diabetes amongst the elderly can present unique challenges. Other disabilities associated with aging can contribute to the complexity of strictly self-managing diabetes. DM complications and co-morbidities are more frequent in old diabetics compared to their young counterparts. Among this age group, diagnosed diabetes is projected to reach 26.7 million by 2050. The prevalence of diabetes among adults is projected to increase to 14% to 33% by 2050. Targeted interventions and expanded surveillance and research and better policies are needed to address the rapidly growing diabetes burden among older adults.

Clinical Diabetes and Diagnostic Approaches:

Approximately one third of patients with Impaired Fasting Glucose or Impaired Glucose Tolerance will develop diabetes within five years. The frequency of symptomatic diabetes has been decreasing in parallel with improved efforts to diagnose diabetes earlier through screening. Some of the diagnostic markers which can be utilized for the type of diabetes a patient is suffering from are blood sugar, HbA1c, c-peptide, GADA, glycated albumin and glycated proteins. However the gold standard for identifying type 1.5 diabetic patients involves the use of immunogenetic markers for the measurement of autoantibodies. Identification of these patients is clinically relevant to their management as the early use of insulin resulted in β-cell preservation in several pilot studies. Improvements in diabetes care and management have been crucial in lowering the incidence and severity of Diabetes. Several therapeutic strategies in the early stages of Diabetes are being evaluated.

Diabetes Technology:

With a health condition like diabetes, where the individual is responsible for round-the-clock self-monitoring, there are many benefits to come from care that is both increasingly automated and personalised for the individual. There are many pieces of diabetes technology or devices that can help you manage your diabetes. Smartphone integration, better automation of insulin delivery, and personalized insights from super computers are just a handful of the advances on the horizon. Most of the current research has centered on the improvement

Metabolic Syndrome:

The importance of the metabolic syndrome is not just related to its high prevalence rate but also because it predicts the development of diabetes and cardiovascular disease. Approximately 20 – 25 percent of the world’s adult population has the cluster of risk factors that is metabolic syndrome. Obesity and sedentary lifestyles are major contributing factors to the syndrome and provide opportunities for interventions. It is currently the third most common cause for liver transplantation and is projected to be the leading cause for liver transplantation in 2020. Data from the World Health Organization suggests 65% of the world's population live in countries where overweight and obesity kills more people than underweight. The International Diabetes Federation reports that as of 2011, 366 million people suffer from diabetes; this number is projected to increase to over half a billion (estimated 552 million) by 2030.

Endocrinology:

Endocrinology is concerned with the integration of developmental events proliferation, growth, differentiation, psychological or behavioral activities of metabolism, growth and development, tissue function, sleep, digestion, respiration, excretion, mood, stress, lactation, movement, reproduction, and sensory perception caused by hormones. Endocrine disease mainly occurs due to hormonal imbalance. The endocrine system influences how your heart beats, how your bones and tissues grow and also even your ability to make a baby. The endocrine system plays a major role in whether or not you develop diabetes, thyroid disease, growth disorders, sexual dysfunction, and a host of other hormone-related disorders.

Diabetes Associated Disorders:

Diabetes mellitus has been associated with a number of musculoskeletal manifestations. A number of studies outline the association between diabetes and cancer. Moreover, type 2 diabetes already causes 5 million deaths per year, mostly from cardiovascular diseases. The literature indicates a strong and consistent increase in the risk of cancer in people with type 2 diabetes. People with diabetes have higher rates of hepatitis B then the general population. These associations have been mainly supported by epidemiological studies, because their pathophysiological mechanisms have not been completely clarified. Identification and treatment of those lesions are important to improve the patients' quality of life.

Diabetes Medications:

Diabetes medications are a common form of treatment for people with diabetes. Most diabetes drugs are designed for people with type 2 diabetes who are unable to control their blood sugar levels through strict diet and exercise alone. A number of research studies indicate that metformin may be beneficial in reducing incidence of a variety of cancers. According to A consensus statement of the European Association and American Diabetes Association for the Study of Diabetes, a tier system is used to prescribe medicines depending on how validated the medication is. The cost associated with diagnosed diabetes was $245 billion in 2012 compared to $174 billion in 2007. Out of $245 billion, $176 billion were the direct medical costs of diabetes.

Management of Diabetes:

It has been observed that diet and lifestyle to a certain extent does play an important role. It has been found and reported that in new cases of diabetes diet and lifestyle advice alone is required to maintain glucose levels in approximately 50%, of cases, while as 20-30% will require oral anti-diabetic treatment and insulin will be needed in 20-30% cases. The main idea and concern is to explore diabetes mellitus in terms of its past historical perspective, biochemical basis, economic burden, management steps along with the future perspectives which needs to be taken to minimize the great loss of damage caused by this metabolic disorder. Nevertheless, the effectiveness of current treatments for Diabetes is limited. Thus, a multidisciplinary approach and novel strategies to detect prevent, and treat Diabetes in the early stages is required.

Gestational Diabetes:

Unlike other types of diabetes, gestational diabetes isn't permanent. Gestational diabetes affects 3–9% of pregnancies, depending on the population studied. Gestational diabetes generally resolves once the baby is born. Based on different studies, the chances of developing GDM in a second pregnancy, if a woman had GDM in her first pregnancy, are between 30 and 84%, depending on ethnic background. A 2015 review found that moderate physical exercise during pregnancy is effective for the prevention of gestational diabetes. More research is needed to find the most effective way for screening gestational diabetes.

Alternative Medical Therapies for Diabetes:

Some people with diabetes might benefit from additional treatments. Although some of these therapies may be effective, others can be ineffective or even harmful. According to research by the Food Standards Agency (FSA) in 2008, nearly a third of people in the UK take some vitamin, mineral or dietary supplement on most days. The main reason to take supplements is for general health and wellbeing. There is some but not enough scientific evidence to suggest that any dietary supplements can help prevent or manage type 2 diabetes or its complications.

Computerised Applications in Diabetes:

The predominance of diabetes is rising internationally. Poor glucose control increases the risk of diabetes-related complexities and an expansion in medicinal services use. Diabetes self-administration (DSME) has appeared to enhance glucose control, and accordingly may diminish long term complexities. Usage of diabetes self-administration instruction projects may not be possible for every one of the establishments or in creating nations because of absence of assets and higher expenses related with DSME preparing. With the expanding utilization of cell phones and Internet, there is a chance to utilize computerized apparatus for preparing individuals with diabetes to self-deal with their sickness. Various versatile applications, Internet entryway, and sites are accessible to help patients to enhance their diabetes mind. Be that as it may, the reviews are constrained to demonstrate its adequacy and money saving advantages in diabetes self-administration. Likewise, there are many difficulties ahead for the advanced industry. Computerized learning technology interventions that can empower patients in self-management of diabetes and support diabetes education over a distance.

Technologies for the Treatment of Diabetes:

The aim of diabetes treatment is to keep, blood glucose levels as near to normal as possible. Recent clinical epidemiologic studies have identified a high co-occurrence rate of diabetes and eating disorders with consequent increase in morbidity - revealing poor diabetes control as a major contributing factor for people with this comorbidity. Normalizing blood sugar levels without imposing other risks have become main focus for Diabetes Research Institute to save millions of children and adults. Though diabetes has no known cure right now, the recent medical advances and discoveries made by researchers, leads to hopeful treatment methodologies and possible ways to cure Diabetes.

Epidemiology of Diabetes:

Prospective studies suggest that the main pathophysiological defects leading to type 2 diabetes are insulin resistance and a relative insulin secretory defect. The main aetiological risk factors are age, obesity, family history and physical inactivity. Dietary risk factors have recently emerged. The disease burden related to diabetes is high and rising in every country mainly fuelled by the global rise in the prevalence of obesity and unhealthy lifestyles. Both forms of diabetes can lead to multisystem complications of microvascular endpoints, including retinopathy, nephropathy and neuropathy, and macrovascular endpoints including ischaemic heart disease, stroke and peripheral vascular disease. The premature morbidity, mortality, reduced life expectancy and financial and other costs of diabetes make it an important public health condition.



Please contact the event manager Marilyn (marilyn.b.turner@nyeventslist.com ) below for:
- Multiple participant discounts
- Price quotations or visa invitation letters
- Payment by alternate channels (PayPal, check, Western Union, wire transfers etc)
- Event sponsorships

NO REFUNDS ALLOWED ON REGISTRATIONS
Service fees included in this listing.
-----------------------------------------------------------------
This event is brought to you by:
Conference Series - NewYorkEventsList
http://www.NyEventsList.com
http://www.BostonEventsList.com
http://www.SFBayEventsList.com
-----------------------------------------------------------------

MYL180428CEV


Share with friends

Date and Time

Location

Berlin

Berlin

Germany

View Map

Refund Policy

No Refunds

Save This Event

Event Saved